This report studies Immune Checkpoint Agents in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Bristol Myers Squibb
Merck
AstraZeneca
Roche
...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Anti-PD-L1 Drug
Anti-PD-1 Drug
CTLA4
By Application, the market can be split into
Lung Cancer
Colorectal Cancer
Breast Cancer?
Prostate Cancer
Melanoma
Blood Cancers
By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Immune Checkpoint Agents Market Professional Survey Report 2017
1 Industry Overview of Immune Checkpoint Agents
1.1 Definition and Specifications of Immune Checkpoint Agents
1.1.1 Definition of Immune Checkpoint Agents
1.1.2 Specifications of Immune Checkpoint Agents
1.2 Classification of Immune Checkpoint Agents
1.2.1 Anti-PD-L1 Drug
1.2.2 Anti-PD-1 Drug
1.2.3 CTLA4
1.3 Applications of Immune Checkpoint Agents
1.3.1 Lung Cancer
1.3.2 Colorectal Cancer
1.3.3 Breast Cancer?
1.3.4 Prostate Cancer
1.3.5 Melanoma
1.3.6 Blood Cancers
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Immune Checkpoint Agents
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Immune Checkpoint Agents
2.3 Manufacturing Process Analysis of Immune Checkpoint Agents
2.4 Industry Chain Structure of Immune Checkpoint Agents
3 Technical Data and Manufacturing Plants Analysis of Immune Checkpoint Agents
3.1 Capacity and Commercial Production Date of Global Immune Checkpoint Agents Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Immune Checkpoint Agents Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Immune Checkpoint Agents Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Immune Checkpoint Agents Major Manufacturers in 2016
4 Global Immune Checkpoint Agents Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Immune Checkpoint Agents Capacity and Growth Rate Analysis
4.2.2 2016 Immune Checkpoint Agents Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Immune Checkpoint Agents Sales and Growth Rate Analysis
4.3.2 2016 Immune Checkpoint Agents Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Immune Checkpoint Agents Sales Price
4.4.2 2016 Immune Checkpoint Agents Sales Price Analysis (Company Segment)
5 Immune Checkpoint Agents Regional Market Analysis
5.1 North America Immune Checkpoint Agents Market Analysis
5.1.1 North America Immune Checkpoint Agents Market Overview
5.1.2 North America 2012-2017E Immune Checkpoint Agents Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Immune Checkpoint Agents Sales Price Analysis
5.1.4 North America 2016 Immune Checkpoint Agents Market Share Analysis
5.2 China Immune Checkpoint Agents Market Analysis
5.2.1 China Immune Checkpoint Agents Market Overview
5.2.2 China 2012-2017E Immune Checkpoint Agents Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Immune Checkpoint Agents Sales Price Analysis
5.2.4 China 2016 Immune Checkpoint Agents Market Share Analysis
5.3 Europe Immune Checkpoint Agents Market Analysis
5.3.1 Europe Immune Checkpoint Agents Market Overview
5.3.2 Europe 2012-2017E Immune Checkpoint Agents Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Immune Checkpoint Agents Sales Price Analysis
5.3.4 Europe 2016 Immune Checkpoint Agents Market Share Analysis
5.4 Southeast Asia Immune Checkpoint Agents Market Analysis
5.4.1 Southeast Asia Immune Checkpoint Agents Market Overview
5.4.2 Southeast Asia 2012-2017E Immune Checkpoint Agents Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Immune Checkpoint Agents Sales Price Analysis
5.4.4 Southeast Asia 2016 Immune Checkpoint Agents Market Share Analysis
5.5 Japan Immune Checkpoint Agents Market Analysis
5.5.1 Japan Immune Checkpoint Agents Market Overview
5.5.2 Japan 2012-2017E Immune Checkpoint Agents Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Immune Checkpoint Agents Sales Price Analysis
5.5.4 Japan 2016 Immune Checkpoint Agents Market Share Analysis
5.6 India Immune Checkpoint Agents Market Analysis
5.6.1 India Immune Checkpoint Agents Market Overview
5.6.2 India 2012-2017E Immune Checkpoint Agents Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Immune Checkpoint Agents Sales Price Analysis
5.6.4 India 2016 Immune Checkpoint Agents Market Share Analysis
6 Global 2012-2017E Immune Checkpoint Agents Segment Market Analysis (by Type)
6.1 Global 2012-2017E Immune Checkpoint Agents Sales by Type
6.2 Different Types of Immune Checkpoint Agents Product Interview Price Analysis
6.3 Different Types of Immune Checkpoint Agents Product Driving Factors Analysis
6.3.1 Anti-PD-L1 Drug of Immune Checkpoint Agents Growth Driving Factor Analysis
6.3.2 Anti-PD-1 Drug of Immune Checkpoint Agents Growth Driving Factor Analysis
6.3.3 CTLA4 of Immune Checkpoint Agents Growth Driving Factor Analysis
7 Global 2012-2017E Immune Checkpoint Agents Segment Market Analysis (by Application)
7.1 Global 2012-2017E Immune Checkpoint Agents Consumption by Application
7.2 Different Application of Immune Checkpoint Agents Product Interview Price Analysis
7.3 Different Application of Immune Checkpoint Agents Product Driving Factors Analysis
7.3.1 Lung Cancer of Immune Checkpoint Agents Growth Driving Factor Analysis
7.3.2 Colorectal Cancer of Immune Checkpoint Agents Growth Driving Factor Analysis
7.3.3 Breast Cancer? of Immune Checkpoint Agents Growth Driving Factor Analysis
7.3.4 Prostate Cancer of Immune Checkpoint Agents Growth Driving Factor Analysis
7.3.5 Melanoma of Immune Checkpoint Agents Growth Driving Factor Analysis
7.3.6 Blood Cancers of Immune Checkpoint Agents Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Immune Checkpoint Agents
8.1 Bristol Myers Squibb
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Bristol Myers Squibb 2016 Immune Checkpoint Agents Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Bristol Myers Squibb 2016 Immune Checkpoint Agents Business Region Distribution Analysis
8.2 Merck
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Merck 2016 Immune Checkpoint Agents Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Merck 2016 Immune Checkpoint Agents Business Region Distribution Analysis
8.3 AstraZeneca
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 AstraZeneca 2016 Immune Checkpoint Agents Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 AstraZeneca 2016 Immune Checkpoint Agents Business Region Distribution Analysis
8.4 Roche
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Roche 2016 Immune Checkpoint Agents Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Roche 2016 Immune Checkpoint Agents Business Region Distribution Analysis
9 Development Trend of Analysis of Immune Checkpoint Agents Market
9.1 Global Immune Checkpoint Agents Market Trend Analysis
9.1.1 Global 2017-2022 Immune Checkpoint Agents Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Immune Checkpoint Agents Sales Price Forecast
9.2 Immune Checkpoint Agents Regional Market Trend
9.2.1 North America 2017-2022 Immune Checkpoint Agents Consumption Forecast
9.2.2 China 2017-2022 Immune Checkpoint Agents Consumption Forecast
9.2.3 Europe 2017-2022 Immune Checkpoint Agents Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Immune Checkpoint Agents Consumption Forecast
9.2.5 Japan 2017-2022 Immune Checkpoint Agents Consumption Forecast
9.2.6 India 2017-2022 Immune Checkpoint Agents Consumption Forecast
9.3 Immune Checkpoint Agents Market Trend (Product Type)
9.4 Immune Checkpoint Agents Market Trend (Application)
10 Immune Checkpoint Agents Marketing Type Analysis
10.1 Immune Checkpoint Agents Regional Marketing Type Analysis
10.2 Immune Checkpoint Agents International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Immune Checkpoint Agents by Region
10.4 Immune Checkpoint Agents Supply Chain Analysis
11 Consumers Analysis of Immune Checkpoint Agents
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 Conclusion of the Global Immune Checkpoint Agents Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Immune Checkpoint Agents
Table Product Specifications of Immune Checkpoint Agents
Table Classification of Immune Checkpoint Agents
Figure Global Production Market Share of Immune Checkpoint Agents by Type in 2016
Figure Anti-PD-L1 Drug Picture
Table Major Manufacturers of Anti-PD-L1 Drug
Figure Anti-PD-1 Drug Picture
Table Major Manufacturers of Anti-PD-1 Drug
Figure CTLA4 Picture
Table Major Manufacturers of CTLA4
Table Applications of Immune Checkpoint Agents
Figure Global Consumption Volume Market Share of Immune Checkpoint Agents by Application in 2016
Figure Lung Cancer Examples
Table Major Consumers in Lung Cancer
Figure Colorectal Cancer Examples
Table Major Consumers in Colorectal Cancer
Figure Breast Cancer? Examples
Table Major Consumers in Breast Cancer?
Figure Prostate Cancer Examples
Table Major Consumers in Prostate Cancer
Figure Melanoma Examples
Table Major Consumers in Melanoma
Figure Blood Cancers Examples
Table Major Consumers in Blood Cancers
Figure Market Share of Immune Checkpoint Agents by Regions
Figure North America Immune Checkpoint Agents Market Size (Million USD) (2012-2022)
Figure China Immune Checkpoint Agents Market Size (Million USD) (2012-2022)
Figure Europe Immune Checkpoint Agents Market Size (Million USD) (2012-2022)
Figure Southeast Asia Immune Checkpoint Agents Market Size (Million USD) (2012-2022)
Figure Japan Immune Checkpoint Agents Market Size (Million USD) (2012-2022)
Figure India Immune Checkpoint Agents Market Size (Million USD) (2012-2022)
Table Immune Checkpoint Agents Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Immune Checkpoint Agents in 2016
Figure Manufacturing Process Analysis of Immune Checkpoint Agents
Figure Industry Chain Structure of Immune Checkpoint Agents
Table Capacity and Commercial Production Date of Global Immune Checkpoint Agents Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Immune Checkpoint Agents Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Immune Checkpoint Agents Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Immune Checkpoint Agents Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Immune Checkpoint Agents 2012-2017
Figure Global 2012-2017E Immune Checkpoint Agents Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Immune Checkpoint Agents Market Size (Value) and Growth Rate
Table 2012-2017E Global Immune Checkpoint Agents Capacity and Growth Rate
Table 2016 Global Immune Checkpoint Agents Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Immune Checkpoint Agents Sales (K Units) and Growth Rate
Table 2016 Global Immune Checkpoint Agents Sales (K Units) List (Company Segment)
Table 2012-2017E Global Immune Checkpoint Agents Sales Price (USD/Unit)
Table 2016 Global Immune Checkpoint Agents Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Immune Checkpoint Agents 2012-2017E
Figure North America 2012-2017E Immune Checkpoint Agents Sales Price (USD/Unit)
Figure North America 2016 Immune Checkpoint Agents Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Immune Checkpoint Agents 2012-2017E
Figure China 2012-2017E Immune Checkpoint Agents Sales Price (USD/Unit)
Figure China 2016 Immune Checkpoint Agents Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Immune Checkpoint Agents 2012-2017E
Figure Europe 2012-2017E Immune Checkpoint Agents Sales Price (USD/Unit)
Figure Europe 2016 Immune Checkpoint Agents Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Immune Checkpoint Agents 2012-2017E
Figure Southeast Asia 2012-2017E Immune Checkpoint Agents Sales Price (USD/Unit)
Figure Southeast Asia 2016 Immune Checkpoint Agents Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Immune Checkpoint Agents 2012-2017E
Figure Japan 2012-2017E Immune Checkpoint Agents Sales Price (USD/Unit)
Figure Japan 2016 Immune Checkpoint Agents Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Immune Checkpoint Agents 2012-2017E
Figure India 2012-2017E Immune Checkpoint Agents Sales Price (USD/Unit)
Figure India 2016 Immune Checkpoint Agents Sales Market Share
Table Global 2012-2017E Immune Checkpoint Agents Sales (K Units) by Type
Table Different Types Immune Checkpoint Agents Product Interview Price
Table Global 2012-2017E Immune Checkpoint Agents Sales (K Units) by Application
Table Different Application Immune Checkpoint Agents Product Interview Price
Table Bristol Myers Squibb Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bristol Myers Squibb Immune Checkpoint Agents Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Bristol Myers Squibb Immune Checkpoint Agents Business Region Distribution
Table Merck Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck Immune Checkpoint Agents Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Merck Immune Checkpoint Agents Business Region Distribution
Table AstraZeneca Information List
Table Product A Overview
Table Product B Overview
Table 2015 AstraZeneca Immune Checkpoint Agents Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 AstraZeneca Immune Checkpoint Agents Business Region Distribution
Table Roche Information List
Table Product A Overview
Table Product B Overview
Table 2016 Roche Immune Checkpoint Agents Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Roche Immune Checkpoint Agents Business Region Distribution
Figure Global 2017-2022 Immune Checkpoint Agents Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Immune Checkpoint Agents Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Immune Checkpoint Agents Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Immune Checkpoint Agents Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Immune Checkpoint Agents Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Immune Checkpoint Agents Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Immune Checkpoint Agents Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Immune Checkpoint Agents Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Immune Checkpoint Agents Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Immune Checkpoint Agents by Type 2017-2022
Table Global Consumption Volume (K Units) of Immune Checkpoint Agents by Application 2017-2022
Table Traders or Distributors with Contact Information of Immune Checkpoint Agents by Region
Executive Summary
Azoth Analytics has released a research report titled "Global Immune Thrombocytopenia Drug Market (2024 Edition)" which provides a complete analysis of the Global Immune Thrombocytopenia Drug industry in terms of market segmentation By Treatment (Intravenous Immunoglob...
Overview of the Global Autologous Immune Cell Storage Market:
The report discusses everything a marketer requires before investing in the global Autologous Immune Cell Storage Market during the forecast period 2023-...
Overview of the Global Neonatal Immune Cell Storage Service Market:
The report discusses everything a marketer requires before investing in the global Neonatal Immune Cell Storage Service Market during the forecast ...
Overview of the Global DNA Damaging Agents Market:
The report discusses everything a marketer requires before investing in the global DNA Damaging Agents Market during the forecast period 2023-2030. It provides deta...
Overview of the Global Immune Cell Banking Service Market:
The report discusses everything a marketer requires before investing in the global Immune Cell Banking Service Market during the forecast period 2023-2030. ...
Overview of the Global Digital Securities Transfer Agents Market:
The report discusses everything a marketer requires before investing in the global Digital Securities Transfer Agents Market during the forecast peri...
Overview of the Global Flavor Masking Agents for Food and Beverages Market:
The report discusses everything a marketer requires before investing in the global Flavor Masking Agents for Food and Beverages Market duri...
Overview of the Global Digital Immune Solutions Market:
The report discusses everything a marketer requires before investing in the global Digital Immune Solutions Market during the forecast period 2023-2030. It pro...
Overview of the Global Healthcare Conversational Agents Market:
The report discusses everything a marketer requires before investing in the global Healthcare Conversational Agents Market during the forecast period 2...
Overview of the Global Health Virtual Agents Market:
The report discusses everything a marketer requires before investing in the global Health Virtual Agents Market during the forecast period 2023-2030. It provides ...